Twist Bioscience (TWST) CFO Adam Laponis Sells Shares

What Happened
Adam Laponis, CFO of Twist Bioscience (TWST), disposed of 1,965 shares on 2026-08-21 at $139.07 per share, for a total transaction value of $273,265. The sale was reported as an open market or private sale but is identified in the filing as a sell-to-cover required to satisfy tax withholding on vested restricted stock units (RSUs), so it was not a discretionary trade.

Key Details

• Transaction date and price: 2026-08-21, 1,965 shares at $139.07 each.
• Total proceeds: $273,265 (gross).
• Shares owned after transaction: Not specified in the provided filing excerpt (see the Form 4 for full holdings).
• Footnotes:
  • F1: Sale represents shares sold to cover tax withholding on RSU vesting — mandated by the issuer's "sell to cover" election, not a discretionary sale.
  • F2: Notes that some shares include those acquired under the Employee Stock Purchase Plan (ESPP) in an exempt transaction under Rules 16b-3(c)/(d).
• Filing timeliness: Transaction dated Aug 21; Form 4 filed Aug 25. This is four calendar days later and appears to be outside the typical two-business-day filing window for Section 16 insiders (see the Form 4 for any explanations).

Context

• Because this was a sell-to-cover tied to RSU vesting, it generally reflects a tax-driven transaction rather than a signal of the CFO’s view on the company.
• Sales to satisfy tax obligations are common after RSU vesting; they differ from discretionary open-market sales that might indicate a change in sentiment.